Hims & Hers Health Stock Rises Over 55% in Pre-Market Trading

Everyday AI News: On March 9th, Hims&Hers Health’s U.S. stock pre-market surged over 55%, now up nearly 45%, reports say the company has reached an licensing agreement with Novo Nordisk for weight loss medication.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin